Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Oak Crest Institute Of Science has 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These filings are distributed across 3 distinct art units, suggesting some technical overlap in their pharmaceutical research. The prosecution involves 4 distinct examiners, meaning each pending action is assigned to a different individual. WRIGHT, SARAH C is the busiest examiner with 1 pending action. The presence of 4 examiners across 3 art units indicates a relatively narrow but varied examination environment.
For a practitioner, the fact that 4 distinct examiners are reviewing 4 pending office actions means that each case requires an individualized approach. While WRIGHT, SARAH C is the busiest examiner, she only manages one of the active matters. The distribution across 3 distinct art units suggests that the institute's work is concentrated within a few specialized biotechnology divisions. This allows for some familiarity with art unit standards, even as the legal team must address the specific preferences of four different examiners. The current prosecution profile shows a balanced workload where no single examiner or art unit holds a majority of the pending cases, requiring consistent attention across the entire biotechnology and pharmaceutical portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WRIGHT, SARAH C | 1 | 42.1% | +45.6% |
| JAUHARI, SACHI | 1 | 60.0% | +80.0% |
| ZHANG SPIERING, DONGXIU | 1 | 41.2% | +65.2% |
| BEANE, RANDALL L | 1 | 32.9% | +36.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18038234 | Vaginal Encapsulation Devices | ZHANG SPIERING, DONGXIU | 18d overdue |
| 18017582 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL RESPIRATORY DISEASES | BEANE, RANDALL L | 70d |
| 18725371 | Subdermal Implant for Sustained Drug Delivery | WRIGHT, SARAH C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18038234 | Vaginal Encapsulation Devices | ZHANG SPIERING, DONGXIU | 18d overdue |
| 18017582 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL RESPIRATORY DISEASES | BEANE, RANDALL L | 70d |
| 18725371 | Subdermal Implant for Sustained Drug Delivery | WRIGHT, SARAH C | — |
| 18287202 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES | JAUHARI, SACHI | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1619 | 1 |
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18725371 | Subdermal Implant for Sustained Drug Delivery | WRIGHT, SARAH C | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18287202 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES | JAUHARI, SACHI | 1654 | §112Other | Non-Final OA | — | Pending | Oct 17, 2023 |
| 18038234 | Vaginal Encapsulation Devices | ZHANG SPIERING, DONGXIU | 1616 | §102§103 | Non-Final OA | 18d overdue | Pending | May 23, 2023 |
| 18017582 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL RESPIRATORY DISEASES | BEANE, RANDALL L | 1654 | §103§112 | Final Rejection | 70d | Pending | Jan 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOak Crest Institute Of Science has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Sarah C Wright has the most, with 1 of Oak Crest Institute Of Science's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
